Global X Data Center & Digital Infra ETF vs Johnson & Johnson — how do they compare? Global X Data Center & Digital Infra ETF trades at $27.65 (market cap $2.04B), while Johnson & Johnson trades at $261.41 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 303× Global X Data Center & Digital Infra ETF's market cap, and Johnson & Johnson pays a 2.09% dividend while Global X Data Center & Digital Infra ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Global X Data Center & Digital Infra ETF for 15 Days and Johnson & Johnson for 129 Days on average.
| DTCR | JNJ | |
|---|---|---|
Market Cap | $2.04B | $618.09B |
Volume | 899,532 | 6,050,983 |
Sector | Sector/Thematic | Health |
52-Week High | $32.46 | $278.43 |
52-Week Low | $19.73 | $186.00 |
Typical Hold Time | 15 Days | 129 Days |
Enterprise Value | — | $646.37B |
Dividend Yield | — | 2.09% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Global X Data Center & Digital Infrastructure ETF seeks exposure to companies involved in data centers and digital infrastructure. Its holdings span areas such as digital infrastructure, networking, and related real estate.
Read more on DTCR →Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →